Changing a TRT provider can involve more than moving a recurring payment. The new clinician needs enough information to assess the treatment, and the existing prescription may have its own refill and monitoring requirements.
This guide is an organizational checklist, not a promise that another clinic will accept a prescription or continue the same plan. A new evaluation can lead to a different recommendation, additional testing, or a decision not to prescribe.
- A new account does not guarantee continuation of a prescription.
- Records, refill timing, and cancellation require separate coordination.
- Follow clinician instructions during the transition.
Gather the record before the appointment
Request relevant consultation notes, diagnostic laboratory reports, follow-up results, and the current medication list. Include the product name, strength, dispensing pharmacy, prescription directions, and when you last used it. Bring the actual label if you can do so securely.
Ask the new clinic which records it accepts and whether it requires a recent examination or a particular laboratory panel. Different providers publish different onboarding requirements. The Defy review offers one example, but the applicable rules must be confirmed with the clinic you are joining.
Make the refill timeline explicit
Tell both care teams how much prescribed medication remains and when the next review is due. Ask who is responsible during the transition. Do not assume that paying the new clinic guarantees a prescription before the old supply ends, or that the previous prescriber can issue a bridge refill without an assessment.
Do not independently increase, reduce, or stop medication to create a particular laboratory result. Ask for explicit instructions from the treating clinician about medication use and test timing. A complete record is more useful than trying to make a result fit an assumed intake threshold.
Separate cancellation from clinical transfer
Cancelling a membership, transferring records, and ending a prescription arrangement are separate events. Ask the old clinic which charges remain, when future billing stops, and whether medication already dispensed can be returned. Do not assume a new provider’s enrollment automatically closes the old account.
Save the relevant confirmations and check the next scheduled charge. Our billing-flexibility comparison explains why a monthly equivalent can conceal a longer payment obligation. Consider both the transition month and the ordinary ongoing bill when comparing costs.
Expect a fresh product discussion
If the new clinician proposes a different pharmacy or formulation, ask for its complete identity and new instructions. A matching ingredient name does not establish an identical concentration, device, cream base, or application routine. The new dispensing pharmacist should explain the product actually supplied.
Read the compounding guide if a preparation’s status changes. Keep both clinicians informed about what you are taking so duplicate or conflicting directions can be resolved before you act on them.
Leave with one agreed plan
At the end of the handoff, you should know the responsible prescriber, current prescription directions, next laboratory date, and contact route for problems. Ask how records will reach your primary-care clinician if care is split between practices.
Our questions-before-TRT article is also useful for a second provider. Changing clinics is an opportunity to clarify the original diagnosis and ongoing benefit, not just to find a lower refill price.
Sources & reading notes
Provider pages describe advertised services, not independently verified outcomes. Prices and eligibility may change. Checked September 20, 2026.
- Endocrine Society: testosterone therapy clinical practice guideline
- Defy Medical: patient requirements (search-indexed FAQ; direct fetch blocked)
- TRT Nation: treatment and laboratory FAQs
- Defy Medical: illustrative TRT costs (search-indexed FAQ; direct fetch blocked)
- Fountain: current TRT plans and billing periods
- FDA: understanding the risks of compounded drugs